Drug Shortage Report for KEVZARA

Last updated on 2022-08-26 History
Report ID 159316
Drug Identification Number 02472961
Brand name KEVZARA
Common or Proper name sarilumab 1.14 mL pre-filled pen
Company Name SANOFI-AVENTIS CANADA INC
Market Status MARKETED
Active Ingredient(s) SARILUMAB
Strength(s) 150MG
Dosage form(s) SOLUTION
Route of administration SUBCUTANEOUS SUBCUTANEOUS
Packaging size 2 pen per carton
ATC code L04AC
ATC description IMMUNOSUPPRESSANTS
Reason for shortage Other (Please describe in comments)
Anticipated start date
Actual start date 2022-04-18
Estimated end date 2022-08-25
Actual end date 2022-08-25
Shortage status Resolved
Updated date 2022-08-26
Company comments Manufacturing delay. The availability date represents estimated availability at the main Sanofi warehouse. Availability dates at a customer’s usual distributor warehouse may vary. Pharmacies are invited to communicate with their preferred distributor to obtain the product availability date.
Health Canada comments
Tier 3 Status No
Company contact information email: CAINTERNET@sanofi.com Telephone: 1-800-265-7927

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v16 2022-08-26 French Compare
v15 2022-08-26 English Compare
v14 2022-08-23 French Compare
v13 2022-08-23 English Compare
v12 2022-08-11 French Compare
v11 2022-08-11 English Compare
v10 2022-07-12 French Compare
v9 2022-07-12 English Compare
v8 2022-07-12 French Compare
v7 2022-07-12 English Compare
v6 2022-05-28 French Compare
v5 2022-05-28 English Compare
v4 2022-04-28 French Compare
v3 2022-04-28 English Compare
v2 2022-04-22 French Compare
v1 2022-04-22 English Compare

Showing 1 to 16 of 16